当前位置: 首页 > 期刊 > 《中国医学创新》 > 202023
编号:13816991
利拉鲁肽对不同体重指数2型糖尿病合并非酒精性脂肪肝患者肝脏脂肪含量及血清FGF-21的影响(4)
http://www.100md.com 2020年8月15日 《中国医学创新》 202023
     [9] Kezhong Zhang,Xiaohua Shen,Jun Wu,et al.Endoplasmic Reticulum Stress Activates Cleavage of CREBH to Induce a Systemic Inflammatory Response[J].Cell,2006,124(3):587-599.

    [10] Tanaka N,Takhashi S,Zhang Y,et al.Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine and choline-deficient diet[J].Biochimica Et Biophysica Acta,2015,1852(7):1242-1252.

    [11] Salminen A,Kauppinen A,Kaarniranta K,et al.FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process[J].Journal of Molecular Medicine,2017,95(2):123-131.

    [12]武繼承,郭林峰,唐道琪,等.GLP-1受体激动剂的临床药效与安全性研究进展[J].药物生物技术,2016,23(4):367-371.

    [13] Jeon J Y,Choi S E,Ha E S,et al.Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles[J].Endocrine,2016,53(1):97-106.

    [14] Lee J,Hong S W,Park S E,et al.Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis[J].Metabolism,2014,63(8):1041-1048.

    [15] Markan K R,Naber M C,Small S M,et al.FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue[J].Mol Metab,2017,6(6):602-610.

    (收稿日期:2020-02-04) (本文编辑:张爽), http://www.100md.com(王欣 王国君)
上一页1 2 3 4